|
|
|
Volumn 33, Issue 5, 2008, Pages 299-302
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOPURINOL;
BENDAMUSTINE;
CHLORAMBUCIL;
FIBRIN GLUE;
HEPATITIS B ANTIBODY;
INSULIN;
TREANDA;
ANAPHYLAXIS;
APOPTOSIS;
BLOOD CLOTTING DISORDER;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BRADYCARDIA;
BULLOUS SKIN DISEASE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
DNA DAMAGE;
DNA REPLICATION;
DRUG APPROVAL;
DRUG DOSE ESCALATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MECHANISM;
DRUG USE;
DRUG WITHDRAWAL;
DYSPNEA;
EDEMA;
FEBRILE NEUTROPENIA;
FEVER;
FLUSHING;
GLUCOSE BLOOD LEVEL;
HEALING IMPAIRMENT;
HEPATITIS B;
HUMAN;
HYPOTENSION;
INFECTION;
INJECTION SITE REACTION;
LIVER TRANSPLANTATION;
MITOSIS INHIBITION;
MULTIPLE CYCLE TREATMENT;
NAUSEA AND VOMITING;
NEUTROPENIA;
NONHUMAN;
NOTE;
PATIENT MONITORING;
PNEUMONIA;
RASH;
SEPSIS;
SEROMA;
SKIN GRAFT;
SKIN TOXICITY;
TACHYCARDIA;
TUMOR LYSIS SYNDROME;
URTICARIA;
|
|
EID: 45349091340
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
